Lurbinectedin Focus - Small Cell Lung Cancer Virtual Roundtable
H. Jack West, MD, Medical Director, Thoracic Oncology Program, Swedish Cancer Institute, Founder & President, Grace Global Resource for Advancing Cancer Education leads this section on new data co...
Author: Cancer-Roundtables
Added: 05/15/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 15, 2018 Category: Cancer & Oncology Source Type: podcasts
Immunotherapy - Small Cell Lung Cancer Virtual Roundtable
H. Jack West, MD, Medical Director, Thoracic Oncology Program, Swedish Cancer Institute, Founder & President, Grace Global Resource for Advancing Cancer Education leads this section on immunothera...
Author: Cancer-Roundtables
Added: 05/15/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 15, 2018 Category: Cancer & Oncology Source Type: podcasts
Small Cell Lung Cancer Virtual Roundtable - ROVA-T
H. Jack West, MD, Medical Director, Thoracic Oncology Program, Swedish Cancer Institute, Founder & President, Grace Global Resource for Advancing Cancer Education leads this section on ROVA-T of a...
Author: Cancer-Roundtables
Added: 05/15/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 15, 2018 Category: Cancer & Oncology Source Type: podcasts
Small Cell Lung Cancer Virtual Roundtable
H. Jack West, MD, Medical Director, Thoracic Oncology Program, Swedish Cancer Institute, Founder & President, Grace Global Resource for Advancing Cancer Education leads a roundtable discussing newly r...
Author: Cancer-Roundtables
Added: 05/15/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 15, 2018 Category: Cancer & Oncology Source Type: podcasts
Are There Clinically Significant Distinctions Between PD-1 and PD-L1_ [720p]
Dr. Jack West, Swedish Cancer Institute, compares the mechanism of action, efficacy and toxicity of PD-1 and PD-L1 inhibitors.
Author: cancergrace
Added: 05/14/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 14, 2018 Category: Cancer & Oncology Source Type: podcasts
Rociletinib_Osimertinib for EGFR T790M-negative NSCLC [720p]
Dr. Jack West, Swedish Cancer Institute, reviews trial evidence for the efficacy of rociletinib and osimertinib for EGFR acquired resistance not driven by a T790M mutation.
Author: cancergrace
Added: 05/14/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 14, 2018 Category: Cancer & Oncology Source Type: podcasts
Maintenance Therapy for Advanced NSCLC [720p]
Dr. Jack West, Swedish Cancer Institute, defines maintenance therapy in advanced NSCLC and discusses maintenance treatment strategies.
Author: cancergrace
Added: 05/14/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 14, 2018 Category: Cancer & Oncology Source Type: podcasts
Bronchoscopy and EBUS [720p]
Dr. Jed Gorden, Swedish Cancer Institute, describes the differences between bronchoscopy and endobronchial ultrasound, highlighting the advantages of EBUS in diagnosis and staging
Author: cancergrace
Added: 05/14/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 14, 2018 Category: Cancer & Oncology Source Type: podcasts
Lung Cancer Screening - Process and Potential Benefits [720p]
Dr. Jed Gorden, Swedish Cancer Institute, reviews the lung cancer screening process, including low-dose CT scanning, smoking cessation, follow-up testing and counseling, and describes the potential be...
Author: cancergrace
Added: 05/12/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 12, 2018 Category: Cancer & Oncology Source Type: podcasts
Immunotherapy as First-Line Treatment [720p]
Dr. Jack West, Swedish Cancer Institute, raises the question of whether to use immune checkpoint inhibitors as first-line treatment of lung cancer, alone or in combination with chemotherapy.
Author: cancergrace
Added: 05/11/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 12, 2018 Category: Cancer & Oncology Source Type: podcasts
Immunotherapy Combinations [720p]
Dr. Jack West, Swedish Cancer Institute, discusses current trials seeking to determine the efficacy of combining immunotherapy agents in lung cancer
Author: cancergrace
Added: 05/11/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 12, 2018 Category: Cancer & Oncology Source Type: podcasts
Research Summaries: Childhood IQ and risk of bipolar disorder in adulthood: prospective birth cohort study
This study focused on association of childhood IQ (which is an imperfect measure of true intelligence) with propensity for bipolar disorder in young adulthood. This study did not look at creativity and did not look at actual occurrence of bipolar disorder, thus all the results should not be extrapolated wildly.
Childhood IQ at age 8 was measured using WISC-III and separate verbal and performance IQ as well as Full IQ scores were used in analysis. Propensity towards bipolar was measured using HCL-32 (hypo-mania checklist) which consist of 32 yes/no answers to statements like ‘I am more easily distracted’ when in...
Source: The Mouse Trap - July 14, 2017 Category: Psychiatry & Psychology Authors: sandygautam Tags: bipolar intelligence Research Summaries Bipolar disorder IQ Source Type: podcasts
Effect of molecular-targeted therapy on the progress and survival of people in the late stages of stomach cancer
Stomach cancer is the fifth most common cancer and third leading cause of cancer-related deaths worldwide. Molecular-targeted therapy is one of the newer treatments and a new Cochrane Review in July 2016 looks at the evidence from randomized trials. Lead author, Huan Song from the Karolinska Institutet in Sweden, tells us more in this podcast. (Source: Podcasts from The Cochrane Library)
Source: Podcasts from The Cochrane Library - December 7, 2016 Category: General Medicine Authors: Cochrane Source Type: podcasts
Psychiatric Meds in Schizophrenia: Effects on Mortality
Dr Peter Yellowlees reviews an observational study from Sweden evaluating the effect of commonly used psychiatric medications on mortality in patients with schizophrenia. (Source: Medscape Psychiatry Podcast)
Source: Medscape Psychiatry Podcast - May 2, 2016 Category: Psychiatry Authors: Medscape Source Type: podcasts
Patient spotlight - Doing it for themselves
In our accompanying roundtable discussion,we hear views from a group of patients and clinicians based largely in the UK on the actions required to advance progress towards providing patient centred care.
To extend the conversation we talked to members of the BMJ's international patient advisory panel and other patient advocates - and what follows are short clips of hour long conversations with people in the US, Europe, India, Equador a nd Uganda.
While the quality of the recordings vary there is no mistaking
the passion of these advocates to improve care for fellow patients and the barriers which need to be overcome...
Source: The BMJ Podcast - February 10, 2015 Category: General Medicine Authors: BMJ talk medicine Source Type: podcasts
